Cynthia L. Gong, PharmD, PhD is a Research Assistant Professor of Pediatrics in the Division of Neonatology and the Fetal and Neonatal Institute at Children’s Hospital Los Angeles, Keck School of Medicine of USC. Supported by Teresa and Byron Pollitt Family Chair in Fetal & Neonatal Medicine, Dr. Gong is a core faculty team member developing fetal and neonatal health economics and outcomes research at Children’s Hospital Los Angeles. Her research primarily focuses on the costs and cost-effectiveness of therapies and policies to estimate whether changes in clinical treatment, guidelines, or policies represent high-value interventions that can optimize the efficiency of limited healthcare resources to yield the best treatment outcomes possible.
Dr. Gong received her PharmD from the USC School of Pharmacy in 2011 and completed a residency in pharmacoeconomics at the VA Northern California Healthcare System. She earned her PhD in health economics at the USC School of Pharmacy, working with faculty from the Schaeffer Center for Health Policy and Economics. Prior to joining CHLA and USC, Dr. Gong was the Senior Pharmacoeconomics Advisor for Stanford Health Care, performing economic evaluations of high cost drugs to support the formulary decision-making process, and assisting in the development of drug cost-savings initiatives throughout the institution.
University of Southern California School of Pharmacy: Doctor of Pharmacy
University of Southern California Schaeffer Center for Health Policy & Economics: Doctor of Philosophy
VA Northern California Health Care System: Pharmacoeconomics Pharmacy Residency
Early onset sepsis calculator-based management of newborns exposed to maternal intrapartum fever: a cost benefit analysis J Perinatol. 2019 Jan 28. View in PubMed
Behavioral Economics Interventions to Improve Outpatient Antibiotic Prescribing for Acute Respiratory Infections: a Cost-Effectiveness Analysis J Gen Intern Med. 2018 May 08. View in PubMed
Prescriber preferences for behavioural economics interventions to improve treatment of acute respiratory infections: a discrete choice experiment BMJ Open. 2016 Sep 22; 6(9):e012739. . View in PubMed
Association between use of warfarin with common sulfonylureas and serious hypoglycemic events: retrospective cohort analysis BMJ. 2015 Dec 07; 351:h6223. . View in PubMed
Cost-effectiveness analysis of abiraterone and sipuleucel-T in asymptomatic metastatic castration-resistant prostate cancer J Natl Compr Canc Netw. 2014 Oct; 12(10):1417-25. . View in PubMed
Dr. Gong's research interests include health economics and behavioral economics, specifically focusing on cost-effectiveness and cost-benefit analyses, and discrete choice experiments, and applying these methodologies to issues in neonatology, such as congenital disease, therapeutic interventions and monitoring, and transition home from the NICU. Dr. Gong’s research is supported by the Teresa & Byron Pollitt Family Chair in Fetal and Neonatal Medicine.
Current Research Studies
Assessing optimal transition to home from the NICU using a discrete choice experiment
Cost-effectiveness of early whole exome sequencing
Cost-effectiveness of prolonged ECMO use in congenital diaphragmatic hernia
Resource utilization associated with hypoplastic left heart syndrome